Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 2/20 | 0.53 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.53 |
| ▸ | PPARG | P37231 | 6/20 | 0.45 |
| ▸ | NCOA2 | Q15596 | 6/20 | 0.45 |
| ▸ | NCOA1 | Q15788 | 6/20 | 0.45 |
| ▸ | RXFP1 | Q9HBX9 | 5/20 | 0.45 |
| ▸ | NCOA3 | Q9Y6Q9 | 5/20 | 0.45 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | ALPG | P10696 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.35 |
| ▸ | GLA | P06280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17285533 | 0.83 | ALDH1A1 (0.61) | MAPTALDH1A1HPGDCYP2C9PPARG | |
| SCHEMBL13548267 | 0.82 | GLA (0.45) | MAPTALDH1A1HPGDCYP2C9GAA | |
| SCHEMBL17285587 | 0.80 | ALDH1A1 (0.57) | MAPTALDH1A1HPGDCYP2C9PPARG | |
| SCHEMBL6320498 | 0.79 | ALDH1A1 (0.56) | MAPTALDH1A1HPGDCYP2C9PPARG | |
| SCHEMBL5795084 | 0.71 | ALDH1A1 (0.63) | MAPTALDH1A1HPGDPPARGNCOA2 | |
| SCHEMBL5791378 | 0.71 | ALDH1A1 (1.00) | MAPTALDH1A1HPGDCYP2C9PPARG | |
| SCHEMBL17285588 | 0.69 | ALDH1A1 (0.63) | MAPTALDH1A1HPGDCYP2C9GAA | |
| SCHEMBL5795561 | 0.69 | ALDH1A1 (0.73) | MAPTALDH1A1HPGDCYP2C9MEN1 | |
| SCHEMBL28136550 | 0.68 | NSD2 (0.47) | MAPTALDH1A1HPGDCYP2C9PPARG | |
| SCHEMBL19655935 | 0.68 | ALDH1A1 (0.51) | MAPTALDH1A1HPGDCYP2C9PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3661932-B1 | COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS | PROMEGA CORP (US) | 2021-10-06 | — | — | EP | disclosed |
| US-11136615-B2 | Compositions and methods for stabilizing benzothiazole luciferin analogs | PROMEGA CORPORATION (US) | 2021-10-05 | — | — | US | disclosed |
| US-20190040449-A1 | COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2019-02-07 | — | — | US | disclosed |
| WO-2019028272-A1 | COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS | PROMEGA CORPORATION (US) | 2019-02-07 | — | — | WO | disclosed |
| EP-3146066-B1 | COMPOSITIONS AND METHODS FOR STABILIZING LUMINOGENIC SUBSTRATES | PROMEGA CORP (US) | 2018-03-14 | — | — | EP | disclosed |
| US-9676997-B2 | Compositions and methods for stabilizing luminogenic substrates | PROMEGA CORPORATION (US) | 2017-06-13 | — | — | US | disclosed |
| US-20150337198-A1 | COMPOSITIONS AND METHODS FOR STABILIZING LUMINOGENIC SUBSTRATES | JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT | 2015-11-26 | — | — | US | disclosed |
| WO-2015179864-A1 | COMPOSITIONS AND METHODS FOR STABILIZING LUMINOGENIC SUBSTRATES | PROMEGA CORPORATION (US) | 2015-11-26 | — | — | WO | disclosed |
| WO-2007017114-A1 | NEW SUBSTITUTED AZATHYMIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF BACTERIAL INFECTIOUS DISEASES | MERLION PHARMACEUTICALS SA (CH) | 2007-02-15 | — | — | WO | disclosed |
| US-7034151-B2 | 1,4-dihydro-4-oxo-pyrrolo[2,1-f][1,2,4]triazine-6-carboxylates; novel approach to the formation of the bicyclic heterocyclic ring system | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-04-25 | — | — | US | disclosed |
| EP-1644353-A1 | AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES | Bayer HealthCare AG (DE) | 2006-04-12 | — | — | EP | disclosed |
| EP-1590335-A4 | PROCESS FOR PREPARING PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL MYERS SQUIBB CO (US) | 2006-03-08 | — | — | EP | disclosed |
| US-20060041124-A1 | Process for preparing pyrrolotriazine kinase inhibitors | CHEN BANG-CHI | 2006-02-23 | — | — | US | disclosed |
| EP-1590335-A2 | PROCESS FOR PREPARING PYRROLOTRIAZINE KINASE INHIBITORS | Bristol-Myers Squibb Company (US) | 2005-11-02 | — | — | EP | disclosed |
| WO-2005003118-A1 | AMIDE-SUBSTITUTED 1,2,4-TRIAZIN-5(2H)-ONES FOR THE TREATMENT OF CHRONICALLY INFLAMMATORY DISEASES | BAYER HEALTHCARE AG (DE) | 2005-01-13 | — | — | WO | disclosed |
| WO-2004072030-A2 | PROCESS FOR PREPARING PYRROLOTRIAZINE KINASE INHIBITORS | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-08-26 | — | — | WO | disclosed |
| US-20040157846-A1 | Process for preparing pyrrolotriazine kinase inhibitors | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190040449-A1 | COMPOSITIONS AND METHODS FOR STABILIZING BENZOTHIAZOLE LUCIFERIN ANALOGS | TK1, TYMP, NUDT1 | MAPT 3613/4885ALDH1A1 2006/4885HPGD 2221/4885 |
| US-20040157846-A1 | Process for preparing pyrrolotriazine kinase inhibitors | MAP3K15, MAP4K2, MAP3K5 | MAPT 1978/4885ALDH1A1 4403/4885HPGD 943/4885 |
| US-11136615-B2 | Compositions and methods for stabilizing benzothiazole luciferin analogs | TK1, TYMP, NUDT1 | MAPT 3613/4885ALDH1A1 2006/4885HPGD 2221/4885 |
| US-20060041124-A1 | Process for preparing pyrrolotriazine kinase inhibitors | MAP3K15, MAP4K2, MAP3K5 | MAPT 1978/4885ALDH1A1 4403/4885HPGD 943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.